Lilyana Amezcua, MD is an Associate Professor of Clinical Neurology, Program Director, Multiple Sclerosis Fellowship Director, Keck Huntington Beach Multiple Sclerosis Infusion Program. She is a board certified neurologist and multiple sclerosis specialist. She joined the USC Department of Neurology as a resident physician in 2003, after having completed her medical degree at Jefferson Medical College and an internal medicine internship at Hahnemann Hospital of Drexel University. She completed a residency in Neurology at USC and served as Chief Resident. In 2006, she received support from the National Multiple Sclerosis Society (NMSS) as a Clinical MS Fellow to develop her expertise in the study and treatment of MS. She was appointed as Assistant Professor of Clinical Neurology in 2008 and Medical Director of the MS Comprehensive Care Center in 2011.
Dr. Amezcua is a recipient of the Nancy Davis Junior Investigator Award and an NIH KL2 award through the USC Clinical and Translational Sciences Institute (CTSI). She serves on multiple local and national committee's of the NMSS: the Clinical Advisory Committee for the California and Nevada Chapter of the NMSS, is a council member of the NMSS Hispanic MS Advisory Board and was recently elected to serve in the Access to Care Task Force of the NMSS. She is also working together with the NMSS to develop and bring MS services to the newly opened Wellness Center of the historic Los Angeles County Hospital.
Dr. Amezcua is a recipient of the Nancy Davis Junior Investigator Award and an NIH KL2 award through the USC Clinical and Translational Sciences Institute (CTSI). She serves on multiple local and national committee's of the NMSS: the Clinical Advisory Committee for the California and Nevada Chapter of the NMSS, is a council member of the NMSS Hispanic MS Advisory Board and was recently elected to serve in the Access to Care Task Force of the NMSS. She is also working together with the NMSS to develop and bring MS services to the newly opened Wellness Center of the historic Los Angeles County Hospital.
Deborah Backus, PT, PhD is Director of Multiple Sclerosis Research at the Shepherd Center in Atlanta, Georgia. Deborah received her B.S. in Physical Therapy in 1986, and her Ph.D. in neuroscience in 2004. She has combined her experiences as a physical therapist, researcher and educator to focus on improving functional and health outcomes for people with neurological injury or disease, specifically related to people with multiple sclerosis (MS) and spinal cord injury (SCI).
As part of the Eula C. and Andrew C. Carlos MS Rehabilitation and Wellness Program at Shepherd Center, she is focusing on the assessment of the health and wellness needs for people at varying stages of MS, and the evaluation of rehabilitation and exercise interventions that may be beneficial to people with MS. Her clinical experience combined with her research interests has fueled a passion for facilitating the translation of evidence into clinical practice, including influencing clinicians in practice, payers for reimbursement of evidence based interventions, and policy makers related to health policy. Dr. Debbie has presented both nationally and internationally, and has also published related to this work.
Deborah has presented both nationally and internationally, and has also published related to this work. She has been recognized for her contributions to rehabilitation by the ACRM (American Congress of Rehabilitation Medicine) with the Deborah L. Wilkerson Early Career Award in Rehabilitation Research (2011), and the Academy of Spinal Cord injury Professionals with the Distinguished Clinical/Research Award (2010), and recently was named a Fellow of ACRM (2014).
Deborah has created "Ask Dr. Debbie" (CLICK HERE) to answer your questions about research.
As part of the Eula C. and Andrew C. Carlos MS Rehabilitation and Wellness Program at Shepherd Center, she is focusing on the assessment of the health and wellness needs for people at varying stages of MS, and the evaluation of rehabilitation and exercise interventions that may be beneficial to people with MS. Her clinical experience combined with her research interests has fueled a passion for facilitating the translation of evidence into clinical practice, including influencing clinicians in practice, payers for reimbursement of evidence based interventions, and policy makers related to health policy. Dr. Debbie has presented both nationally and internationally, and has also published related to this work.
Deborah has presented both nationally and internationally, and has also published related to this work. She has been recognized for her contributions to rehabilitation by the ACRM (American Congress of Rehabilitation Medicine) with the Deborah L. Wilkerson Early Career Award in Rehabilitation Research (2011), and the Academy of Spinal Cord injury Professionals with the Distinguished Clinical/Research Award (2010), and recently was named a Fellow of ACRM (2014).
Deborah has created "Ask Dr. Debbie" (CLICK HERE) to answer your questions about research.
Tad Campbell, MCN, RD, LD is a registered dietitian in Dallas, Texas. He currently works with Multiple Sclerosis patients at the University of Texas Southwestern Medical Center’s Total Life Care (TLC) MS clinic. In addition to his clinical role, Mr. Campbell also serves as the Education Coordinator for the Clinical Nutrition department in UT Southwestern’s School of Health Professions teaching Food Science and Technology and working with potential, new, and existing students who are interested in beginning a career in nutrition and dietetics.
Mr. Campbell was a faculty speaker at the 2013 Consortium of Multiple Sclerosis Centers conference where he presented “A Global Approach to the At-Risk MS Patient - Role of the Dietitian” along with his colleagues from the TLC clinic.
Mr. Campbell was a faculty speaker at the 2013 Consortium of Multiple Sclerosis Centers conference where he presented “A Global Approach to the At-Risk MS Patient - Role of the Dietitian” along with his colleagues from the TLC clinic.
Jeffrey Dunn, MD, FAAN serves as Professor of Clinical Neurology and Division Chief of Clinical Neuroimmunology in the Department of Neurology and Neurosciences at Stanford University (Stanford, California; USA). His research efforts includes collaborative translational research to identify biomarkers of MS and NMO disease status and therapeutic targets, and the clinical phenotypes of MS according to ethnic heritage; and he has served as Principal Investigator in more than 20 clinical trials of new and emerging immunotherapeuticals for MS. Dr. Dunn is an elected member of the Executive Committee of the MS Section of the American Academy of Neurology. He has been awarded the prestigious Henry J. Kaiser Family Foundation Award for Excellence in Clinical Teaching, and the Arthur Bloomfield Award in recognition of excellence in the teaching of clinical medicine.
Brittany Goods is a doctoral candidate in Biological Engineering at the Massachusetts Institute of Technology. She received a Bachelor of Engineering degree at Dartmouth College and a Bachelor of Arts degree in Biochemistry at Colby College. She is currently an NSF graduate research fellow at MIT in Chris Love’s lab. Her research is focused in clinical immunology, with the goal of applying novel computational and experimental techniques to study multiple sclerosis. Brittany will be writing for our Multiple Perspectives in Multiple Sclerosis series.
Sarah Frank, PT, DPT, MSCS, is a physical therapist who works primarily with people who have Multiple Sclerosis. She obtained the Multiple Sclerosis Specialist Certification (MSCS) in 2013, which is a certification confirming a higher knowledge and skill set to work with people who have Multiple Sclerosis.
She works at Mount Sinai Rehab Hospital and the Mandell Center for Multiple Sclerosis, in Hartford, CT; where she has been a member of the MS rehab team for 5 years. As part of the rehab team, she works closely with the occupational therapists, speech language pathologists, medical staff, and fitness staff to provide the best care possible to patients. As a physical therapist, she performs comprehensive PT evaluations and treatments for persons with MS in order to help maximize their function, mobility, and safety at home and in the community.
Sarah obtained her Doctor of Physical Therapy degree from Sacred Heart University in Fairfield, CT. Before that she obtained a Bachelor’s degree in Biology from Iona College, in New Rochelle, NY.
She works at Mount Sinai Rehab Hospital and the Mandell Center for Multiple Sclerosis, in Hartford, CT; where she has been a member of the MS rehab team for 5 years. As part of the rehab team, she works closely with the occupational therapists, speech language pathologists, medical staff, and fitness staff to provide the best care possible to patients. As a physical therapist, she performs comprehensive PT evaluations and treatments for persons with MS in order to help maximize their function, mobility, and safety at home and in the community.
Sarah obtained her Doctor of Physical Therapy degree from Sacred Heart University in Fairfield, CT. Before that she obtained a Bachelor’s degree in Biology from Iona College, in New Rochelle, NY.
Benjamin M. Greenberg, M.D., M.H.S., is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology at UT Southwestern Medical Center. He also has an appointment in the Department of Pediatrics.
Dr. Greenberg is an internationally recognized expert in treating rare autoimmune disorders of the central nervous system.
He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children’s Medical Center – which he established as one of only two U.S. programs of its kind.
Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago’s Rush Presbyterian-St. Luke’s Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine, serving as Chief Resident his final year.
He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor’s degree in the history of medicine – both from Johns Hopkins.
Dr. Greenberg splits his clinical time between adult and pediatric patients, routinely consulting on the inpatient units of William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children’s Medical Center.
His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.
In addition, Dr. Greenberg has led an effort to improve biorepository development and create uniform protocols for sample handling and analysis. As part of this initiative, his collaborative research has identified novel biomarkers that could be key to distinguishing between patients with various neurologic disorders.
Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-director of the nation’s first dedicated Transverse Myelitis Center.
Certified by the American Board of Psychiatry and Neurology, Dr. Greenberg is a three-time Texas Monthly Rising Star and was included in D Magazine's Best Doctors list for 2018 and 2020. He was also named a Super Doctor by Texas Monthly in 2018.
Dr. Greenberg is an internationally recognized expert in treating rare autoimmune disorders of the central nervous system.
He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children’s Medical Center – which he established as one of only two U.S. programs of its kind.
Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago’s Rush Presbyterian-St. Luke’s Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine, serving as Chief Resident his final year.
He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor’s degree in the history of medicine – both from Johns Hopkins.
Dr. Greenberg splits his clinical time between adult and pediatric patients, routinely consulting on the inpatient units of William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children’s Medical Center.
His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.
In addition, Dr. Greenberg has led an effort to improve biorepository development and create uniform protocols for sample handling and analysis. As part of this initiative, his collaborative research has identified novel biomarkers that could be key to distinguishing between patients with various neurologic disorders.
Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-director of the nation’s first dedicated Transverse Myelitis Center.
Certified by the American Board of Psychiatry and Neurology, Dr. Greenberg is a three-time Texas Monthly Rising Star and was included in D Magazine's Best Doctors list for 2018 and 2020. He was also named a Super Doctor by Texas Monthly in 2018.
Revere (Rip) Kinkel, MD has over 30 years of experience treating Multiple Sclerosis patients. He is currently Professor of Neurosciences, Clinical Neurology Director and Director of the multiple sclerosis program at the University of California, San Diego. He was previously Division Chief and Director of the multiple sclerosis program at Beth Israel Deaconess Medical Center/Harvard Medical School from 2002 to 2013 and Medical Director of the Mellen Center for MS treatment and research at the Cleveland Clinic Foundation from 1995 to 2002.
Dr Kinkel serves on the national advisory board of the National MS Society and as medical director of the Accelerated Cure Project, a non-profit organization devoted to facilitating international research into the cause and management of MS. Dr Kinkel has over 150 publications in peer reviewed journals and books. His recent research utilizes high field imaging to study the pathogenesis of corticol demyelination and injury in MS.
His clinical and research work remains entirely focused on MS and he maintains a very active full time clinic in addition to his teaching, research and administrative responsibilities. The number for his clinic is (858) 822-5861.
Dr. Kinkel firmly believes in the integration of complementary and alternative therapies into standard medical and rehabilitative management of MS. Dr. Kinkel remains devoted to providing education to people with MS and is co-founder of healthcarejourney.com.
Disclosure: Dr Kinkel has received honoraria in the past 5 years for serving as a scientific consultant or speaker for the following companies: Avanir pharmaceuticals, Acorda, Biogen Idec, Genzyme, Ironwood pharmaceuticals and Teva. He has received research support in the past 5 years from Biogen Idec, the National Multiple Sclerosis Society, the National Institute of Health and the Department of Defense. Dr Kinkel does not own any stock or serve on any boards of pharmaceutical or medical device companies or any insurance companies. He is the Chief Medical Officer of the Accelerated Cure Project, a non profit organization dedicated to researching the cause and treatments of MS.
Dr Kinkel serves on the national advisory board of the National MS Society and as medical director of the Accelerated Cure Project, a non-profit organization devoted to facilitating international research into the cause and management of MS. Dr Kinkel has over 150 publications in peer reviewed journals and books. His recent research utilizes high field imaging to study the pathogenesis of corticol demyelination and injury in MS.
His clinical and research work remains entirely focused on MS and he maintains a very active full time clinic in addition to his teaching, research and administrative responsibilities. The number for his clinic is (858) 822-5861.
Dr. Kinkel firmly believes in the integration of complementary and alternative therapies into standard medical and rehabilitative management of MS. Dr. Kinkel remains devoted to providing education to people with MS and is co-founder of healthcarejourney.com.
Disclosure: Dr Kinkel has received honoraria in the past 5 years for serving as a scientific consultant or speaker for the following companies: Avanir pharmaceuticals, Acorda, Biogen Idec, Genzyme, Ironwood pharmaceuticals and Teva. He has received research support in the past 5 years from Biogen Idec, the National Multiple Sclerosis Society, the National Institute of Health and the Department of Defense. Dr Kinkel does not own any stock or serve on any boards of pharmaceutical or medical device companies or any insurance companies. He is the Chief Medical Officer of the Accelerated Cure Project, a non profit organization dedicated to researching the cause and treatments of MS.
Lori Ann Kostich M.S. CCC-SLP, MSCS is a Speech-Language Pathologist working at the Mandell Center for Multiple Sclerosis in Hartford, Connecticut. She is responsible for the evaluation and treatment of patient's having difficulty with swallow function (dysphagia), speech production (dysarthria) and/or cognitive-communication/cognitive-linguistic function. Lori has a particular interest in incorporating current research into clinical practice, and in providing early, appropriate intervention for symptoms related to Multiple Sclerosis.
Ellen Lathi, MD, is the director of the MS Center at St. Elizabeth’s Medical Center as well as a well-known speaker on treatment issues and wellness in multiple sclerosis. She is involved in numerous clinical trials at the center relating to the treatment of MS and is widely recognized for her clinical expertise and comprehensive approach to patient care. She also directs the MS Service Dog Program, sponsored by the NMSS, in which highly trained dogs are trained to assist patients with MS. In addition, Dr Lathi has been repeatedly recognized as one of Boston Magazine’s “Best Doctors” and one of US News and World Reports’“Top Doctors”, and she has received the prestigious Physician Health Care Professional Volunteer award from the Central New England Chapter of the National MS Society. She is a member of the American Academy of Neurology, Chairman of the Clinical Advisory Committee of the Greater New England Chapter of the National MS Society and a member of the Consortium of MS Centers.
Augusto Miravalle, MD is a board certified neurologist who sub-specializes in Multiple Sclerosis and related neuro-immunological disorders of the brain and spinal cord. He completed his neurology residency training at Loyola University, Chicago where he served as chief resident in Neurology. He completed a clinical fellowship in MS and related disorders at Beth Israel Deaconess Medical Center, Harvard Medical School. Dr Miravalle has particular interest in gray matter pathology, particularly neocortical volume changes, cortical lesions, and their impact on cognitive and physical disability. He sees patients at the University of Colorado Hospital Anschutz Centers for Advanced Medicine at the Fitzsimons campus. Dr. Miravalle is a member of the University of Colorado Multiple Sclerosis Center. Dr Miravalle’s clinical and research work in MS is complemented by a very active administrative responsibilities in Medical Education, serving as Vice Chair for Education and Residency Program Director for the Department of Neurology, University of Colorado.
Disclosure: Dr. Miravalle does not own any stock or serve on any boards of pharmaceutical or medical device companies or any insurance companies.
Disclosure: Dr. Miravalle does not own any stock or serve on any boards of pharmaceutical or medical device companies or any insurance companies.
Marie A. Namey has been helping multiple sclerosis patients for over 29 years. She had been part of the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic Foundation since its inception in 1985.
Marie has received the June Halper Award for excellence in MS Nursing, the Excellence in Advanced Practice Nursing Award, and has been inducted into the National MS Society Health Professional Volunteer Hall of Fame.
Marie is a popular speaker for patient and professional groups on aspects of MS care, is on the Editorial Board for Real Living with MS, and has published on topics of bladder/bowel function and adherence in MS.
She is a founding member and currently is a Past President of the International Organization of Multiple Sclerosis Nurses (IOMSN), is a board member of the Consortium of Multiple Sclerosis Centers (chairs the advocacy committee), and a member of the local MS Society Chapter Professional Advisory Committee and the Chapter Program Committee. Marie is also a member of the Health Advisory Committee for the Multiple Sclerosis Association of America.
Disclosure:
Speakers Bureau: Biogen Idec, Teva Neuroscience, Acorda Therapeutics, Novartis, Genzyme, EMD Serono
Consulting: Biogen Idec, Teva Neuroscience, Serono, Acorda Therapeutics, Novartis, Allergan, Genzyme
Royalties: none; Stocks, Bonds, Options: none; Other Equity Interest: none; Patents, Intellectual Property Rights: none; Grant Support: none; Clinical Procedures: none
Marie has received the June Halper Award for excellence in MS Nursing, the Excellence in Advanced Practice Nursing Award, and has been inducted into the National MS Society Health Professional Volunteer Hall of Fame.
Marie is a popular speaker for patient and professional groups on aspects of MS care, is on the Editorial Board for Real Living with MS, and has published on topics of bladder/bowel function and adherence in MS.
She is a founding member and currently is a Past President of the International Organization of Multiple Sclerosis Nurses (IOMSN), is a board member of the Consortium of Multiple Sclerosis Centers (chairs the advocacy committee), and a member of the local MS Society Chapter Professional Advisory Committee and the Chapter Program Committee. Marie is also a member of the Health Advisory Committee for the Multiple Sclerosis Association of America.
Disclosure:
Speakers Bureau: Biogen Idec, Teva Neuroscience, Acorda Therapeutics, Novartis, Genzyme, EMD Serono
Consulting: Biogen Idec, Teva Neuroscience, Serono, Acorda Therapeutics, Novartis, Allergan, Genzyme
Royalties: none; Stocks, Bonds, Options: none; Other Equity Interest: none; Patents, Intellectual Property Rights: none; Grant Support: none; Clinical Procedures: none
A. Scott Nielsen, MD, MMSc serves as an MS neurologist at Kaiser Permanente in Fontana, CA. He has been involved in MS patient care since 2001 at the University of Colorado MS center, Beth Israel Deaconess Medical Center/Harvard Medical School, Virginia Mason and now in his current position at Kaiser Permanente.
Dr. Nielsen completed an MS clinical and experimental therapeutics fellowship at Harvard Medical School (2009 to 2011). He was awarded the Sylvia Lawry Physician Fellowship Award by the National MS Society and matriculated in the Scholars in Clinical Sciences Program at Harvard Medical School. His thesis on innovative technology in the care of MS patients yielded a Masters in Medical Sciences degree with an emphasis on translational research. Dr. Nielsen’s fellowship research encompassed the study of ultra-high field MRI and cortical demyelination in MS, development of internet portal use in the care of MS patients, and experimental therapeutics in MS. Current research includes a clinical-biorepository of MS patients in collaboration with the Benaroya Research Institute in Seattle, WA. Dr. Nielsen also continues to work on MRI biomarkers to monitor the MS disease process and response to therapy with the intent to validate their use in the routine clinical care of all patients with MS.
His research and clinic work is focused on MS. The number for his clinic is (206) 341-0420 and the website link is https://www.virginiamason.org/MS.
Disclosure: Dr. Nielsen has received honoraria in the past 5 years as a speaker for Teva and Biogen Idec. He has received research support in the past 5 years from the National MS Society and the NIH (through a KL2 institutional grant to Harvard Medical School).
Dr. Nielsen completed an MS clinical and experimental therapeutics fellowship at Harvard Medical School (2009 to 2011). He was awarded the Sylvia Lawry Physician Fellowship Award by the National MS Society and matriculated in the Scholars in Clinical Sciences Program at Harvard Medical School. His thesis on innovative technology in the care of MS patients yielded a Masters in Medical Sciences degree with an emphasis on translational research. Dr. Nielsen’s fellowship research encompassed the study of ultra-high field MRI and cortical demyelination in MS, development of internet portal use in the care of MS patients, and experimental therapeutics in MS. Current research includes a clinical-biorepository of MS patients in collaboration with the Benaroya Research Institute in Seattle, WA. Dr. Nielsen also continues to work on MRI biomarkers to monitor the MS disease process and response to therapy with the intent to validate their use in the routine clinical care of all patients with MS.
His research and clinic work is focused on MS. The number for his clinic is (206) 341-0420 and the website link is https://www.virginiamason.org/MS.
Disclosure: Dr. Nielsen has received honoraria in the past 5 years as a speaker for Teva and Biogen Idec. He has received research support in the past 5 years from the National MS Society and the NIH (through a KL2 institutional grant to Harvard Medical School).
Brant Oliver, PhD, MS, MPH, APRN-BC, MSCN is a healthcare improvement scientist and dual board certified nurse practitioner (APRN-BC) in family practice and psychiatry/mental health (FNP-BC, PMHNP-BC). He is a certified MS specialist (MSCN) with over ten years of clinical experience in MS care and subspecializes in multiple sclerosis mental health care. His MS related research and academic interests include biopsychosocial disability and coping/self-efficacy, system-based healthcare process and outcomes improvement, and shared decision making. He practices at the Multiple Sclerosis Specialty Care Program at Concord Hospital in Concord, NH, is Assistant Professor at the MGH Institute of Health Professions in Boston, MA, and a Faculty Senior Scholar in the Department of Veterans Affairs National Quality Scholars (VAQS) fellowship program.
Benjamin J. Osborne, MD, is an attending physician in the Department of Neurology and an associate professor of neurology and ophthalmology at MedStar Georgetown University Hospital. Dr. Osborne is board certified in neurology, with concentrations in neuro-opthalmology and multiple sclerosis.
Dr. Osborne evaluates and treats patients with complicated vision problems (usually due to neurologic disease) whom are referred by other specialists. The neurological diseases that often cause such vision problems that Dr. Osborne treats include multiple sclerosis, myasthenia gravis, pseudotumor cerebri, thyroid eye disease, unexplained vision loss, optic neuritis and papilledema. Dr. Osborne and his team participate in field testing and optic coherence tomography (OCT). He has published numerous works in journals in his fields, and is currently active in multiple ongoing research studies.
Dr. Osborne evaluates and treats patients with complicated vision problems (usually due to neurologic disease) whom are referred by other specialists. The neurological diseases that often cause such vision problems that Dr. Osborne treats include multiple sclerosis, myasthenia gravis, pseudotumor cerebri, thyroid eye disease, unexplained vision loss, optic neuritis and papilledema. Dr. Osborne and his team participate in field testing and optic coherence tomography (OCT). He has published numerous works in journals in his fields, and is currently active in multiple ongoing research studies.
David Rintell Ed.D. is on the staff of the Partners MS Center at the Brigham & Women's Hospital in Boston, the Partners Pediatric MS Center at Massachusetts General Hospital, Boston, and the MS Clinic of Metro West Medical Center, Framingham, Mass. Dr. Rintell is a Clinical Instructor in Psychiatry at Harvard Medical School, and is also on the faculty of the Brandeis University Genetic Counseling Program.
PLEASE NOTE: The medical information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information does not create any patient-physician relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.
